Form 8.3 - Amendment-March 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Form 8.3 - Amendment

Mar 10, 2026 10:30 PM

LONDON--(BUSINESS WIRE)--

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

(a) Full name of discloser	Qube Research & Technologies Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree	AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure	12-12-2025
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”	N/A

2. INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security (Note 3)	$0.01 ordinary shares
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled	989,981	1.01	0	0
(2) Cash-settled derivatives	0	0	0	0
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell	0	0	0	0
Total	989,981	1.01	0	0

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit (Note 5)
$0.01 ordinary shares	Purchase	28,976	21.36
$0.01 ordinary shares	Purchase	2,785	21.39
$0.01 ordinary shares	Purchase	2,125	21.35
$0.01 ordinary shares	Purchase	1,856	21.4
$0.01 ordinary shares	Purchase	1,763	21.41
$0.01 ordinary shares	Purchase	578	21.38
$0.01 ordinary shares	Purchase	537	21.37
$0.01 ordinary shares	Purchase	300	21.42
$0.01 ordinary shares	Purchase	219	21.385
$0.01 ordinary shares	Purchase	132	21.365
$0.01 ordinary shares	Purchase	118	21.415
$0.01 ordinary shares	Purchase	40	21.34
$0.01 ordinary shares	Purchase	18	21.395
$0.01 ordinary shares	Purchase	3	21.3778
$0.01 ordinary shares	Sale	10,417	21.385
$0.01 ordinary shares	Sale	7,858	21.395
$0.01 ordinary shares	Sale	5,574	21.405
$0.01 ordinary shares	Sale	2,330	21.37
$0.01 ordinary shares	Sale	1,686	21.375
$0.01 ordinary shares	Sale	1,202	21.415
$0.01 ordinary shares	Sale	700	21.41
$0.01 ordinary shares	Sale	300	21.36
$0.01 ordinary shares	Sale	200	21.39
$0.01 ordinary shares	Sale	100	21.42
$0.01 ordinary shares	Sale	100	21.38
$0.01 ordinary shares	Sale	91	21.3778

Ap29

(b) Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position	Number of reference securities (Note 6)	Price per unit (Note 5)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates (Note 6)	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii) Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 3)

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

Ap30

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

(c) Attachments

Is a Supplemental Form 8 attached?

Class of relevant security (Note 3)	$0.01 ordinary shares
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled	989,981	1.01	0	0
(2) Cash-settled derivatives	0	0	0	0
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell	0	0	0	0
Total	989,981	1.01	0	0

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251215765451/en/

Source: Qube Research & Technologies LTD

Previous page： Can-Fite BioPharma's Partner Reports Positive Study Results of Piclidenoson in Dogs With Osteoarthritis Next page： BRIEF-Blue-Touch Holdings Group Says Ac Sunshine Securities Llc Is Underwriter To Us IPO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments